Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Terrence R Burke

Showing results (21-30 of 169) with videos related to

Pageof 17
Sort By:
Bioorganic & Medicinal Chemistry|March 14, 2017
Enhancing polo-like kinase 1 selectivity of polo-box domain-binding peptidesXue Zhi Zhao, David Hymel, Terrence R Burke
Expert Opinion on Therapeutic Targets|July 16, 2008
Grb2 signaling in cell motility and cancerAlessio Giubellino, Terrence R Burke, Donald P Bottaro
Bioorganic & Medicinal Chemistry Letters|September 15, 2016
Application of oxime-diversification to optimize ligand interactions within a cryptic pocket of the polo-like kinase 1 polo-box domainXue Zhi Zhao, David Hymel, Terrence R Burke
Bioorganic & Medicinal Chemistry Letters|February 26, 2004
Design and synthesis of photoactivatable aryl diketo acid-containing HIV-1 integrase inhibitors as potential affinity probesXuechun Zhang, Christophe Marchand, Yves Pommier, et al.
Bioorganic & Medicinal Chemistry Letters|November 7, 2002
Design and synthesis of a beta-amino phosphotyrosyl mimetic suitably protected for peptide synthesisKyeong Lee, Manchao Zhang, Dajun Yang, et al.
The EMBO Journal|February 17, 2006
Retroviral DNA integration: reaction pathway and critical intermediatesMin Li, Michiyo Mizuuchi, Terrence R Burke, et al.
Bioorganic & Medicinal Chemistry Letters|October 17, 2008
Application of a trifunctional reactive linker for the construction of antibody-drug hybrid conjugatesJoshua D Thomas, Thomas Hofer, Christoph Rader, et al.
The Journal of Biological Chemistry|July 5, 2012
Chemically programmed bispecific antibodies that recruit and activate T cellsHuiting Cui, Joshua D Thomas, Terrence R Burke, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 23, 2008
An engineered selenocysteine defines a unique class of antibody derivativesThomas Hofer, Joshua D Thomas, Terrence R Burke, et al.
Molecules (Basel, Switzerland)|April 25, 2019
Development of Highly Selective 1,2,3-Triazole-containing Peptidic Polo-like Kinase 1 Polo-box Domain-binding InhibitorsXue Zhi Zhao, Kohei Tsuji, David Hymel, et al.
Pageof 17

Showing results (21-30 of 169) with videos related to

Sort By:
Pageof 17
Bioorganic & Medicinal Chemistry|March 14, 2017
Enhancing polo-like kinase 1 selectivity of polo-box domain-binding peptidesXue Zhi Zhao, David Hymel, Terrence R Burke
Expert Opinion on Therapeutic Targets|July 16, 2008
Grb2 signaling in cell motility and cancerAlessio Giubellino, Terrence R Burke, Donald P Bottaro
Bioorganic & Medicinal Chemistry Letters|September 15, 2016
Application of oxime-diversification to optimize ligand interactions within a cryptic pocket of the polo-like kinase 1 polo-box domainXue Zhi Zhao, David Hymel, Terrence R Burke
Bioorganic & Medicinal Chemistry Letters|February 26, 2004
Design and synthesis of photoactivatable aryl diketo acid-containing HIV-1 integrase inhibitors as potential affinity probesXuechun Zhang, Christophe Marchand, Yves Pommier, et al.
Bioorganic & Medicinal Chemistry Letters|November 7, 2002
Design and synthesis of a beta-amino phosphotyrosyl mimetic suitably protected for peptide synthesisKyeong Lee, Manchao Zhang, Dajun Yang, et al.
The EMBO Journal|February 17, 2006
Retroviral DNA integration: reaction pathway and critical intermediatesMin Li, Michiyo Mizuuchi, Terrence R Burke, et al.
Bioorganic & Medicinal Chemistry Letters|October 17, 2008
Application of a trifunctional reactive linker for the construction of antibody-drug hybrid conjugatesJoshua D Thomas, Thomas Hofer, Christoph Rader, et al.
The Journal of Biological Chemistry|July 5, 2012
Chemically programmed bispecific antibodies that recruit and activate T cellsHuiting Cui, Joshua D Thomas, Terrence R Burke, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 23, 2008
An engineered selenocysteine defines a unique class of antibody derivativesThomas Hofer, Joshua D Thomas, Terrence R Burke, et al.
Molecules (Basel, Switzerland)|April 25, 2019
Development of Highly Selective 1,2,3-Triazole-containing Peptidic Polo-like Kinase 1 Polo-box Domain-binding InhibitorsXue Zhi Zhao, Kohei Tsuji, David Hymel, et al.
Pageof 17